S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORRELATED WITH SURVIVAL OUTCOMES IN JANUS KINASE INHIBITOR (JAKI) RELAPSED OR REFRACTORY (R/R) MYELOFIBROSIS (MF) PATIENTS (PTS)

Autor:	Pankit Vachhani, Andrew Perkins, John Mascarenhas, Haifa Kathrin Al-Ali, Jean-Jacques Kiladjian, Sonia Cerquozzi, Jaroslaw Dybko, Regina Garcia Delgado, Jesus Hernández Rivas, Holger Hebart, Zhuying Huang, Cecile Krejsa, Hope Qamoos, Jesse Mcgreivy, Wayne P. Rothbaum, Srdan Verstovsek, Alessandro Vannucchi
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Diseases of the blood and blood-forming organs RC633-647.5
Zdroj:	HemaSphere, Vol 7, p e05521ca (2023)
Druh dokumentu:	article
ISSN:	2572-9241
DOI:	10.1097/01.HS9.0000967768.05521.ca
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/261ee9a28228476d9e8db2a327ebc354 Zobrazit plný text záznamu Plný text View record in DOAJ